BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19641220)

  • 21. Adaptation and validation of DNA synthesis detection by fluorescent dye derivatization for high-throughput screening.
    Ranall MV; Gabrielli BG; Gonda TJ
    Biotechniques; 2010 May; 48(5):379-86. PubMed ID: 20569211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
    Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
    J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and purification of PI3 kinase alpha and development of an ATP depletion and an alphascreen PI3 kinase activity assay.
    Boldyreff B; Rasmussen TL; Jensen HH; Cloutier A; Beaudet L; Roby P; Issinger OG
    J Biomol Screen; 2008 Dec; 13(10):1035-40. PubMed ID: 19036708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel fluorescent probe for fluorescence correlation spectroscopic detection of kinase inhibitors.
    Kawaguchi M; Terai T; Utata R; Kato M; Tsuganezawa K; Tanaka A; Kojima H; Okabe T; Nagano T
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3752-5. PubMed ID: 18524589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format.
    Pommereau A; Pap E; Kannt A
    J Biomol Screen; 2004 Aug; 9(5):409-16. PubMed ID: 15296640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
    Lin LG; Xie H; Li HL; Tong LJ; Tang CP; Ke CQ; Liu QF; Lin LP; Geng MY; Jiang H; Zhao WM; Ding J; Ye Y
    J Med Chem; 2008 Aug; 51(15):4419-29. PubMed ID: 18610999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of LanthaScreen cellular assays for key components within the PI3K/AKT/mTOR pathway.
    Carlson CB; Robers MB; Vogel KW; Machleidt T
    J Biomol Screen; 2009 Feb; 14(2):121-32. PubMed ID: 19196698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MALDI-TOF mass-spectrometry-based versatile method for the characterization of protein kinases.
    Kondo N; Nishimura S
    Chemistry; 2009; 15(6):1413-21. PubMed ID: 19115309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action.
    Navratilova I; Macdonald G; Robinson C; Hughes S; Mathias J; Phillips C; Cook A
    J Biomol Screen; 2012 Feb; 17(2):183-93. PubMed ID: 22068706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
    Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
    J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a fluorescent intensity assay amenable for high-throughput screening for determining 15-lipoxygenase activity.
    Dahlström M; Forsström D; Johannesson M; Huque-Andersson Y; Björk M; Silfverplatz E; Sanin A; Schaal W; Pelcman B; Forsell PK
    J Biomol Screen; 2010 Jul; 15(6):671-9. PubMed ID: 20581078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microarrays for the functional analysis of the chemical-kinase interactome.
    Horiuchi KY; Wang Y; Diamond SL; Ma H
    J Biomol Screen; 2006 Feb; 11(1):48-56. PubMed ID: 16314406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence polarization competition immunoassay for tyrosine kinases.
    Seethala R
    Methods; 2000 Sep; 22(1):61-70. PubMed ID: 11020319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.
    Kolb P; Kipouros CB; Huang D; Caflisch A
    Proteins; 2008 Oct; 73(1):11-8. PubMed ID: 18384152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a 1-microl scale assay for mitogen-activated kinase kinase 7 using 2-D fluorescence intensity distribution analysis anisotropy.
    Wright PA; Boyd HF; Bethell RC; Busch M; Gribbon P; Kraemer J; Lopez-Calle E; Mander TH; Winkler D; Benson N
    J Biomol Screen; 2002 Oct; 7(5):419-28. PubMed ID: 14599357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small-molecule protein and lipid kinase inhibitors in inflammation and specific models for their evaluation.
    Gaestel M; Kotlyarov A
    Methods Mol Biol; 2012; 795():35-44. PubMed ID: 21960213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of mammalian diacylglycerol kinase activity in vitro and in cells.
    Epand RM; Topham MK
    Methods Enzymol; 2007; 434():293-304. PubMed ID: 17954254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidimensional profiling of CSF1R screening hits and inhibitors: assessing cellular activity, target residence time, and selectivity in a higher throughput way.
    Uitdehaag JC; Sünnen CM; van Doornmalen AM; de Rouw N; Oubrie A; Azevedo R; Ziebell M; Nickbarg E; Karstens WJ; Ruygrok S
    J Biomol Screen; 2011 Oct; 16(9):1007-17. PubMed ID: 21873591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a high-throughput screening assay for the hepatitis C virus p7 viroporin.
    Gervais C; Dô F; Cantin A; Kukolj G; White PW; Gauthier A; Vaillancourt FH
    J Biomol Screen; 2011 Mar; 16(3):363-9. PubMed ID: 21343600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.